Jobs / United States / Regeneron Pharmaceuticals INC
Associate Director, Clinical Scientist, Genetics Medicine
Regeneron Pharmaceuticals INC · 🇺🇸 3 Locations
Sponsorship verdict
Sponsorship possible
One solid signal, not two — worth applying, and worth asking about sponsorship early.
- Employer is on a government sponsor recordThe US Department of Labor certified 290 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 40 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
- The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
- No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
- What Regeneron Pharmaceuticals INC paid sponsored hires in similar roles1 certified filing for “Associate Director – Clinical Data Operations” (Database Architects) in NJ: $197k–$197k, median $197k. Most were filed at wage level IV (100%) — 4 lottery entries, ≈61% projected selection odds for cap-subject employers. Source: US Department of Labor LCA disclosure data (Oct 2025 – Jun 2026).
- Confirmed live todayWhen a source last listed this job as open.
US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).
A verdict summarises public evidence; it is not legal advice and never a guarantee — the employer and the immigration authority decide. Sign in to factor in where you can already work.
Or apply yourself on the official page →
Sponsor Radar — Regeneron Pharmaceuticals INC
The US Department of Labor certified 290 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 40 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
Past sponsorship or register membership never guarantees sponsorship for this vacancy or for you. Full Sponsor Radar for Regeneron Pharmaceuticals INC →
About the role
Build our future together: At Regeneron, we use science and innovation to develop life-changing medicines for people with serious diseases. We are seeking an Associate Director, Clinical Sciences to join our Clinical Development Unit, supporting our clinical programs in a matrixed, cross-functional environment. In this role, you will lead the design, execution, and scientific interpretation of clinical studies across early and late phase development, ensuring the integrity of study data and the safety of patients. You will collaborate closely with Medical Directors, regulatory, and other cross-functional partners to move promising candidates forward. This position offers the opportunity to contribute to a fast-growing, science-driven organization making a meaningful difference to patients worldwide. When & where: • Location: Tarrytown, NY, Warren, NJ, Cambridge, MA • Work model/flexibility: Primarily on-site with hybrid flexibility Discover your role: • Lead or support clinical science strategy for a program, serving as lead Clinical Scientist or delegate to the Therapeutic Area Lead • Partner with Medical Directors to design and deliver clinical studies grounded in disease biology and current literature • Develop the Expanded Synopsis and author or review the clinical sections of protocols, amendments, and study reports • Prepare medical monitoring plans, SAPs, and informed consents, and resolve cross-functional comments with minimal guidance • Perform clinical data review and safety monitoring to protect patient safety and data integrity • Present at program team meetings, advisory boards, steering committees, DMCs, and investigator meetings • Identify risks, design mitigation strategies, and drive process improvements across studies • Influence across functions and mentor junior colleagues with confidence, creativity, and professional diplomacy This role requires: • Bachelor’s degree and 10+ years of pharmaceutical clinical drug development experience (other levels considered depending on experience) • Proficient knowledge of the drug development process, ICH/GCP guidelines, study design, and clinical research methodology • Demonstrated leadership in conducting global clinical trials and executing clinical programs • Strong cross-functional leadership, interpersonal, and problem-solving skills in a matrix environment • Solid medical writing skills • Preferred: Advanced degree in life science or healthcare (PhD, MD, PharmD, or MSc) • Preferred: Proven track record of clinical trial process improvements and experience across early and late phase development Does this sound like you? Apply now to take your first step towards living the Regeneron Way! We are committed to building a workplace with an inclusive culture. Regeneron is an equal opportunity employer and all qualified applicants will receive consideration for employment without regard to race, color, religion or belief (or lack thereof), sex, sexual orientation, gender identity or expression, gender reassignment, marital or civil partnership status, civil status, pregnancy or parental status, age, disability, nationality, citizenship status, ethnic or national origin, membership of the Traveler community, familial status, genetic information, military or veteran status, or any other characteristic protected under applicable law. Where required, we will provide reasonable accommodation to applicants with known disabilities or chronic illnesses during the recruitment process, unless such accommodation would impose undue hardship. Where necessary, we disclose salary ranges for roles in all countries in which we operate. The final offer will be determined within the relevant range based on the country of employment, specific role level, and your skil